earticle

논문검색

국내 건강보험심사청구자료에 근거한 다빈도 치료중복 의약품 약효군 분석

원문정보

Analysis of Frequent Therapeutic Duplication Drug Classes Based on National Health Insurance Claimed Data in Korea

손현순, 이영숙, 최경업, 신현택

피인용수 : 0(자료제공 : 네이버학술정보)

초록

영어

Therapeutic duplication of prescriptions is the most frequently reported inappropriate drug use in Korea. To prevent significant problems during drug prescribing and dispensing, prospectively, development of standard including drug lists considered as therapeutic duplications for the prioritized drug classes first would be necessary. This study was aimed to analyze frequent drug classes of therapeutic duplications by healthcare providers in clinical practice settings. National health claims data for drug review and reimbursement (1,426,065 prescriptions dated March 19, 2008) were analyzed. Therapeutic duplication was defined as the prescription including more than 2 ingredients belonging to the same KFDA drug classification numbers that considered to have therapeutic similarities. The following 3 drug classes were mostly frequent therapeutic duplication classes: 114 anti-pyretics, analgesics and anti-inflammatory drugs; 117 drugs for psycho- nervous system; 141 Antihistamines. About 3.5% of overall prescriptions analyzed showed therapeutic duplications. This result might be starting step to develop DUR therapeutic duplication standard.

목차

연구방법
  분석대상 데이타베이스
  치료중복의 정의
  분석방법
  연구결과
  다빈도 처방 의약품 약효군 및 다빈도 치료중복 의약품약효군
 고찰 및 결론
 참고문헌

저자정보

  • 손현순 Hyun Soon Sohn. 숙명여자대학교 약학대학
  • 이영숙 Young Sook Lee. 원광대학교 약학대학
  • 최경업 Kyung Eob Choi. 건강보험심사평가원
  • 신현택 Hyun Taek Shin. 건강보험심사평가원

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 기관로그인 시 무료 이용이 가능합니다.

      • 4,000원

      0개의 논문이 장바구니에 담겼습니다.